Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Cancers|September 10, 2021
Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE TreatmentsAlex J McCraw, Jitesh Chauhan, Heather J Bax, et al.The Journal of Biological Chemistry|July 21, 2012
Mapping of the CD23 binding site on immunoglobulin E (IgE) and allosteric control of the IgE-Fc epsilonRI interactionSusmita Borthakur, Richard G Hibbert, Marie O Y Pang, et al.Mabs|November 27, 2019
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.Scientific Reports|July 31, 2014
A tool kit for rapid cloning and expression of recombinant antibodiesTihomir S Dodev, Panagiotis Karagiannis, Amy E Gilbert, et al.Oncotarget|June 2, 2016
Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Heather J Bax, Debra H Josephs, et al.Journal of Experimental & Clinical Cancer Research : CR|February 11, 2025
An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activitiesLais C G F Palhares, Melanie Grandits, Katie Stoker, et al.Ebiomedicine|April 9, 2019
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural statesGiulia Pellizzari, Coran Hoskin, Silvia Crescioli, et al.Oncotarget|November 5, 2017
BRAF inhibitors: resistance and the promise of combination treatments for melanomaMerope Griffin, Daniele Scotto, Debra H Josephs, et al.Oncoimmunology|September 13, 2021
In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpartFrancis Man, Alexander Koers, Panagiotis Karagiannis, et al.Oncoimmunology|May 10, 2019
Immune mediator expression signatures are associated with improved outcome in ovarian carcinomaMano Nakamura, Heather J Bax, Daniele Scotto, et al.Pageof 6